Aclaris Therapeutics
ACRS
ACRS
96 hedge funds and large institutions have $130M invested in Aclaris Therapeutics in 2025 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 30 increasing their positions, 28 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
96
Holders Change
-12
Holders Change %
-11.11%
% of All Funds
1.29%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
24
Increased
30
Reduced
28
Closed
36
Calls
$5K
Puts
–
Net Calls
+$5K
Net Calls Change
-$29K
Top Buyers
| 1 |
BlackRock
New York
|
$7.83M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
$9.46M |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
$3.5M |
| 4 |
Morgan Stanley
New York
|
$5.03M |
| 5 |
PAI
Palo Alto Investors
Palo Alto,
California
|
$1.97M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
CM
126
Capula Management
Grand Cayman,
Cayman Islands
| – | -$23.9K | -15,593 | Closed |
|
127
Commonwealth Equity Services
Waltham,
Massachusetts
| – | -$22K | -14,694 | Closed |
|
128
Hudson Bay Capital Management
Stamford,
Connecticut
| – | -$18.7K | -12,200 | Closed |
|
|
PCM
129
Prelude Capital Management
New York
| – | -$18K | -11,791 | Closed |
|
|
BHCM
130
Brevan Howard Capital Management
St. Helier,
Jersey
| – | -$17.4K | -11,373 | Closed |
|
|
PD
131
Point72 (DIFC)
Dubai,
United Arab Emirates
| – | -$9.38K | -6,132 | Closed |
|
|
TRCT
132
Tower Research Capital (TRC)
New York
| – | -$5.15K | -3,413 | Closed |
|